Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cannaflos Research Labs is a German biotechnology and pharmaceutical company specializing in the development of standardized cannabis-based medicinal products. Headquartered in Berlin, the company focuses on bridging the gap between botanical medicine and pharmaceutical standards through rigorous research and quality control. Their product portfolio includes high-purity cannabinoid extracts designed for the treatment of chronic pain, spasticity, and other neurological conditions. Cannaflos is notably associated with leading experts in cannabinoid therapy and emphasizes evidence-based clinical applications. The company operates as a licensed pharmaceutical wholesaler and manufacturer, ensuring GMP-compliant production for the European market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cannaflos Research Labs.